Active, not recruitingPhase 1NCT03725007
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis
Studying Juvenile idiopathic arthritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- AbbVie
- Principal Investigator
- ABBVIE INC.AbbVie
- Intervention
- Upadacitinib(drug)
- Enrollment
- 124 enrolled
- Eligibility
- 2-17 years · All sexes
- Timeline
- 2019 – 2027
Study locations (30)
- Ann & Robert H Lurie Children's Hospital of Chicago /ID# 211162, Chicago, Illinois, United States
- Duplicate_University of Louisville /ID# 202896, Louisville, Kentucky, United States
- Boston Children's Hospital /ID# 202993, Boston, Massachusetts, United States
- Cincinnati Childrens Hospital Medical Center /ID# 209697, Cincinnati, Ohio, United States
- Randall Children's Hospital /ID# 213609, Portland, Oregon, United States
- Children's Hospital of Philadelphia /ID# 209617, Philadelphia, Pennsylvania, United States
- Children's Hospital of Pittsburgh of UPMC /ID# 202994, Pittsburgh, Pennsylvania, United States
- Seattle Children's Hospital /ID# 203003, Seattle, Washington, United States
- Alberta Children's Hospital /ID# 251738, Calgary, Alberta, Canada
- British Columbia Children and Women's Hospital and Health Centre /ID# 251736, Vancouver, British Columbia, Canada
- Duplicate_McGill University Health Centre /ID# 251252, Montreal, Quebec, Canada
- Asklepios Klinik Sankt Augustin /ID# 203264, Sankt Augustin, North Rhine-Westphalia, Germany
- St. Josef-Stift Sendenhorst /ID# 244740, Sendenhorst, North Rhine-Westphalia, Germany
- PRI - Pediatric Rheumatology Research Institute /ID# 205954, Bad Bramstedt, Schleswig-Holstein, Germany
- Helios Klinikum Berlin-Buch /ID# 206859, Berlin, Germany
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03725007 on ClinicalTrials.govOther trials for Juvenile idiopathic arthritis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE3NCT07386587Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic ArthritisUniversity of Child Health Sciences and Children's Hospital, Lahore
- RECRUITINGPHASE3NCT06654882Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic ArthritisDuke University
- RECRUITINGNCT07243782Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in KoreaNovartis Pharmaceuticals
- RECRUITINGNANCT07217782Pain in Juvenile ArthritisWashington University School of Medicine
- RECRUITINGNCT07185750Investigation of Catastrophizing of Pain Reported by Parents in JIA PatientsHacettepe University
- RECRUITINGNANCT07234747Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic ArthritisIstanbul University - Cerrahpasa
- RECRUITINGNCT06806774Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic ArthritisHacettepe University
- RECRUITINGNANCT06474546Feasibility of a Diet Intervention for Juvenile ArthritisThe Hospital for Sick Children